US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zhengye Biotechnology Holding Limited

2.04

+0.15007.94%

Post-market: 1.98-0.0600-2.94%19:46 EDT

Volume:279.08K

Turnover:577.67K

Market Cap:60.64M

PE:-9.68

High:2.20

Open:1.85

Low:1.85

Close:1.89

52wk High:13.08

52wk Low:0.6155

Shares:29.73M

Float Shares:4.42M

Volume Ratio:0.61

T/O Rate:6.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2108

EPS(LYR):-0.2105

ROE:-25.17%

ROA:-9.48%

PB:1.63

PE(LYR):-9.69

Loading ...

Overview Company News Filings

Zhengye Biotechnology receives deficiency notice over minimum bid price

Zhengye Biotechnology gets Nasdaq notice for US$ 1 minimum bid price deficiency

Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

THOMSON REUTERS

Zhengye Biotech FY25 net loss widens to RMB 83 million; revenue drops 37.6% to RMB 116.4 million

Zhengye Biotechnology FY EPS $(0.21) Down From $0.03 YoY, Sales $16.639M Down From $25.531M YoY

Benzinga Earnings

Press Release: Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results

Zhengye Biotechnology files Form 3 for director Hu Qiyi

Zhengye Biotechnology implements dual-class share structure with 20-vote Class B shares

Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure

Zhengye Biotechnology Holding held its annual general meeting; 43.13 million shares were represented

Zhengye Biotechnology Holding Ltd. Co-CEO Aiden Han Files Initial Beneficial Ownership Statement

Zhengye Biotechnology Holding Ltd. Vice General Manager Lian Wei files initial beneficial ownership statement

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM

Zhengye Biotechnology Independent Director Wenbin Wang Resigns

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:04 PM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ZYBT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ZYBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZYBT\",,,,,undefined,":{"symbol":"ZYBT","market":"US","secType":"STK","nameCN":"Zhengye Biotechnology Holding Limited","latestPrice":2.04,"timestamp":1787342400000,"preClose":1.89,"halted":0,"volume":279078,"hourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":2.04,"latestTime":"19:46 EDT","volume":28481,"amount":56305.4087,"timestamp":1787356018722,"change":-0.06,"changeRate":-0.029412,"amplitude":0.034314},"delay":0,"changeRate":0.07936507936507944,"floatShares":4418600,"shares":29725000,"eps":-0.2108,"marketStatus":"Market Closed","change":0.15,"latestTime":"08-21 16:00:00 EDT","open":1.85,"high":2.2,"low":1.85,"amount":577674.71532,"amplitude":0.185185,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2108,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1736226000000,"exchange":"NASDAQ","adjPreClose":1.89,"preHourTrading":{"tag":"盘前","latestPrice":1.9,"preClose":1.89,"latestTime":"09:19 EDT","volume":4135,"amount":7734.99716,"timestamp":1787318344162,"change":0.01,"changeRate":0.005291,"amplitude":0.056772},"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":2.04,"latestTime":"19:46 EDT","volume":28481,"amount":56305.4087,"timestamp":1787356018722,"change":-0.06,"changeRate":-0.029412,"amplitude":0.034314},"volumeRatio":0.6114070501505848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZYBT\",,,,,undefined,":{"symbol":"ZYBT","floatShares":4418600,"roa":"-9.48%","roe":"-25.17%","lyrEps":-0.210526,"volumeRatio":0.6114070501505848,"shares":29725000,"dividePrice":0,"high":2.2,"amplitude":0.185185,"preClose":1.89,"low":1.85,"week52Low":0.6155,"pbRate":"1.63","psRate":"3.50","week52High":13.08,"institutionHeld":0,"latestPrice":2.04,"eps":-0.2108,"divideRate":0,"volume":279078,"delay":0,"ttmEps":-0.2108,"open":1.85,"prevYearClose":1.15,"prevWeekClose":1.56,"prevMonthClose":1.33,"prevQuarterClose":0.6771,"fiveDayClose":1.56,"twentyDayClose":1.73,"sixtyDayClose":0.8667},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZYBT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZYBT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZYBT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZYBT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZYBT","date":"2026-08-21","current":-9.677419,"percent":0.246914,"low":-36.833929,"twenty":-13.537007,"median":68.185332,"eighty":137.310542,"high":379.012698,"avg":67.161093,"sd":85.197663,"marketCap":89569700},"quantilePoints":[{"date":"2025-01-10","current":76.710637,"twenty":71.567579,"median":76.710637,"eighty":80.390036,"marketCap":212248692},{"date":"2025-01-17","current":79.949526,"twenty":74.044455,"median":76.449737,"eighty":79.446304,"marketCap":221210303},{"date":"2025-01-24","current":75.908275,"twenty":74.013801,"median":76.048556,"eighty":79.697915,"marketCap":211305364},{"date":"2025-01-31","current":74.51348,"twenty":73.626786,"median":75.690427,"eighty":78.295303,"marketCap":208475381},{"date":"2025-02-07","current":70.830967,"twenty":72.138612,"median":74.956722,"eighty":77.243076,"marketCap":197155451},{"date":"2025-02-14","current":83.762154,"twenty":72.105861,"median":74.136418,"eighty":77.243076,"marketCap":233001897},{"date":"2025-02-21","current":84.745931,"twenty":72.542674,"median":75.399965,"eighty":79.949526,"marketCap":236956880},{"date":"2025-02-28","current":73.80583,"twenty":72.542674,"median":74.776936,"eighty":78.69147,"marketCap":205678571},{"date":"2025-03-07","current":74.148417,"twenty":72.542674,"median":74.148417,"eighty":78.57074,"marketCap":207574226},{"date":"2025-03-14","current":75.140294,"twenty":72.662903,"median":74.284719,"eighty":78.226452,"marketCap":210417709},{"date":"2025-03-21","current":68.23179,"twenty":72.662903,"median":74.463354,"eighty":78.541059,"marketCap":190987245},{"date":"2025-03-28","current":91.656793,"twenty":72.706429,"median":75.090343,"eighty":79.949526,"marketCap":255913430},{"date":"2025-04-04","current":81.475293,"twenty":72.794106,"median":75.399965,"eighty":82.712025,"marketCap":227004691},{"date":"2025-04-11","current":68.343376,"twenty":72.542674,"median":75.090343,"eighty":82.693785,"marketCap":189565504},{"date":"2025-04-17","current":129.928907,"twenty":72.433471,"median":75.164853,"eighty":83.026805,"marketCap":361122285},{"date":"2025-04-25","current":179.634597,"twenty":72.638857,"median":75.690427,"eighty":85.104249,"marketCap":499979016},{"date":"2025-05-02","current":177.167407,"twenty":72.697724,"median":76.136527,"eighty":91.423423,"marketCap":494292051},{"date":"2025-05-09","current":173.267024,"twenty":72.776571,"median":76.710637,"eighty":121.30885,"marketCap":485761604},{"date":"2025-05-16","current":128.303705,"twenty":72.818538,"median":78.230532,"eighty":131.848771,"marketCap":361122285},{"date":"2025-05-23","current":163.781364,"twenty":72.835572,"median":78.57074,"eighty":139.726791,"marketCap":461118088},{"date":"2025-05-30","current":137.310542,"twenty":73.07881,"median":79.406222,"eighty":143.555519,"marketCap":387661455},{"date":"2025-06-06","current":105.398147,"twenty":73.418276,"median":80.718485,"eighty":145.395519,"marketCap":298091755},{"date":"2025-06-13","current":122.161417,"twenty":73.563155,"median":82.712025,"eighty":143.555519,"marketCap":345483131},{"date":"2025-06-20","current":135.841362,"twenty":73.65551,"median":83.762154,"eighty":142.860889,"marketCap":383396231},{"date":"2025-06-27","current":118.047416,"twenty":73.783483,"median":84.59441,"eighty":142.860889,"marketCap":334109200},{"date":"2025-07-03","current":101.300271,"twenty":73.820773,"median":86.58481,"eighty":141.514696,"marketCap":286717824},{"date":"2025-07-11","current":201.410878,"twenty":73.901065,"median":90.338688,"eighty":143.110964,"marketCap":317522219},{"date":"2025-07-18","current":176.563269,"twenty":74.013801,"median":92.248973,"eighty":151.281303,"marketCap":278187377},{"date":"2025-07-25","current":166.365978,"twenty":74.138818,"median":98.478834,"eighty":154.556685,"marketCap":263022136},{"date":"2025-08-01","current":166.79752,"twenty":74.168936,"median":100.530882,"eighty":163.570485,"marketCap":262074309},{"date":"2025-08-08","current":171.191981,"twenty":74.264495,"median":101.38931,"eighty":165.506267,"marketCap":269656929},{"date":"2025-08-15","current":228.836829,"twenty":74.347412,"median":105.21048,"eighty":166.711212,"marketCap":360648371},{"date":"2025-08-22","current":201.576503,"twenty":74.473379,"median":107.744048,"eighty":170.626649,"marketCap":317522219},{"date":"2025-08-29","current":264.982723,"twenty":74.618862,"median":117.339447,"eighty":172.586814,"marketCap":420361505},{"date":"2025-09-05","current":235.510964,"twenty":75.040392,"median":119.254931,"eighty":173.267024,"marketCap":372970129},{"date":"2025-09-12","current":274.699983,"twenty":75.140294,"median":122.161417,"eighty":176.563269,"marketCap":436474572},{"date":"2025-09-19","current":282.228654,"twenty":75.189413,"median":125.55713,"eighty":179.634597,"marketCap":448796330},{"date":"2025-09-26","current":89.674905,"twenty":75.399965,"median":126.606168,"eighty":194.735231,"marketCap":142174128},{"date":"2025-10-03","current":76.06555,"twenty":75.140294,"median":124.551547,"eighty":183.073467,"marketCap":120848008},{"date":"2025-10-10","current":81.230035,"twenty":75.189413,"median":120.505959,"eighty":179.634597,"marketCap":128904542},{"date":"2025-10-17","current":76.42069,"twenty":75.399965,"median":118.600626,"eighty":177.925032,"marketCap":121321922},{"date":"2025-10-24","current":75.198109,"twenty":75.189413,"median":110.618156,"eighty":177.167407,"marketCap":119426267},{"date":"2025-10-31","current":70.004115,"twenty":74.51348,"median":105.864451,"eighty":176.893388,"marketCap":111369733},{"date":"2025-11-07","current":63.238809,"twenty":74.148417,"median":103.280709,"eighty":176.563269,"marketCap":100469717},{"date":"2025-11-14","current":63.912995,"twenty":73.80583,"median":101.218763,"eighty":176.425541,"marketCap":101891458},{"date":"2025-11-21","current":61.367036,"twenty":73.408708,"median":99.14666,"eighty":173.445535,"marketCap":97626234},{"date":"2025-11-28","current":62.007656,"twenty":72.835572,"median":98.345925,"eighty":173.393175,"marketCap":99047975},{"date":"2025-12-05","current":65.18181,"twenty":72.677405,"median":91.818929,"eighty":173.289636,"marketCap":104261027},{"date":"2025-12-12","current":60.030206,"twenty":71.950349,"median":90.338688,"eighty":173.261743,"marketCap":96204493},{"date":"2025-12-19","current":-31.698295,"twenty":71.309788,"median":87.595906,"eighty":173.088367,"marketCap":87200131},{"date":"2025-12-26","current":-28.822706,"twenty":70.464688,"median":86.58481,"eighty":172.955732,"marketCap":79617511},{"date":"2026-01-02","current":-19.678052,"twenty":69.483207,"median":86.099653,"eighty":172.277643,"marketCap":54500082},{"date":"2026-01-09","current":-19.480438,"twenty":68.276424,"median":85.077721,"eighty":171.28687,"marketCap":54026168},{"date":"2026-01-16","current":-18.91999,"twenty":65.717302,"median":84.404895,"eighty":171.149069,"marketCap":52604427},{"date":"2026-01-23","current":-18.426086,"twenty":65.089931,"median":83.302561,"eighty":171.078978,"marketCap":51182686},{"date":"2026-01-30","current":-15.997937,"twenty":64.080547,"median":82.693785,"eighty":170.626649,"marketCap":44595284},{"date":"2026-02-06","current":-12.732029,"twenty":63.733552,"median":81.352664,"eighty":168.586045,"marketCap":35543532},{"date":"2026-02-13","current":-17.055096,"twenty":63.537977,"median":79.949526,"eighty":167.215003,"marketCap":47865289},{"date":"2026-02-20","current":-15.214566,"twenty":63.198838,"median":79.420363,"eighty":166.896161,"marketCap":42652238},{"date":"2026-02-27","current":-13.552834,"twenty":61.926218,"median":78.722501,"eighty":166.79752,"marketCap":38368058},{"date":"2026-03-06","current":-13.152372,"twenty":60.030206,"median":78.541059,"eighty":166.365978,"marketCap":36965273},{"date":"2026-03-13","current":-12.975345,"twenty":-12.674771,"median":78.187292,"eighty":165.784346,"marketCap":36586142},{"date":"2026-03-20","current":-18.403333,"twenty":-12.886333,"median":76.710637,"eighty":164.393953,"marketCap":51656599},{"date":"2026-03-27","current":-14.300522,"twenty":-13.004476,"median":76.278363,"eighty":163.971227,"marketCap":40074147},{"date":"2026-04-02","current":-15.278758,"twenty":-13.280148,"median":76.074883,"eighty":163.819337,"marketCap":42960282},{"date":"2026-04-10","current":-16.553621,"twenty":-13.759624,"median":75.690427,"eighty":162.937846,"marketCap":46917462},{"date":"2026-04-17","current":-17.192962,"twenty":-14.309539,"median":75.193761,"eighty":162.086225,"marketCap":48813117},{"date":"2026-04-24","current":-15.372675,"twenty":-14.818325,"median":75.040392,"eighty":159.907403,"marketCap":43604805},{"date":"2026-05-01","current":-15.370102,"twenty":-14.863008,"median":74.488417,"eighty":158.80589,"marketCap":43600065},{"date":"2026-05-08","current":-4.51547,"twenty":-14.85891,"median":74.251012,"eighty":157.269674,"marketCap":46329809},{"date":"2026-05-15","current":-4.377014,"twenty":-14.818325,"median":74.059783,"eighty":156.176061,"marketCap":45017068},{"date":"2026-05-22","current":-4.006307,"twenty":-14.755934,"median":73.80583,"eighty":154.994234,"marketCap":41097801},{"date":"2026-05-29","current":-3.729639,"twenty":-14.706944,"median":73.580127,"eighty":154.179144,"marketCap":38391753},{"date":"2026-06-05","current":-3.81585,"twenty":-14.594067,"median":73.344805,"eighty":153.533112,"marketCap":39334842},{"date":"2026-06-12","current":-4.141335,"twenty":-14.496269,"median":72.838304,"eighty":152.717958,"marketCap":42652238},{"date":"2026-06-18","current":-3.557883,"twenty":-14.420602,"median":72.794106,"eighty":152.052766,"marketCap":36728316},{"date":"2026-06-26","current":-3.512682,"twenty":-14.327572,"median":72.671967,"eighty":150.871469,"marketCap":36069576},{"date":"2026-07-02","current":-3.122973,"twenty":-14.292392,"median":72.514333,"eighty":149.42586,"marketCap":32083961},{"date":"2026-07-10","current":-3.562829,"twenty":-14.259826,"median":71.765113,"eighty":148.392732,"marketCap":36586142},{"date":"2026-07-17","current":-3.473195,"twenty":-14.254921,"median":71.447862,"eighty":146.943798,"marketCap":35780488},{"date":"2026-07-24","current":-8.280218,"twenty":-14.254921,"median":70.830967,"eighty":143.75,"marketCap":85304476},{"date":"2026-07-31","current":-6.246194,"twenty":-14.236023,"median":70.423624,"eighty":143.361039,"marketCap":64452271},{"date":"2026-08-07","current":-9.582464,"twenty":-13.640524,"median":69.516856,"eighty":142.110664,"marketCap":99047975},{"date":"2026-08-14","current":-7.007846,"twenty":-13.552834,"median":68.685094,"eighty":139.130823,"marketCap":72508805},{"date":"2026-08-21","current":-8.633009,"twenty":-13.537007,"median":68.185332,"eighty":137.310542,"marketCap":89569700}],"updateTime":1787442170257},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZYBT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641524167","title":"Zhengye Biotechnology receives deficiency notice over minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2641524167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641524167?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:40","pubTimestamp":1780605638,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology (ZYBT) announced that on May 29, the company received a written notification from the Nasdaq Stock Market indicating that it ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zhengye-biotechnology-receives-deficiency-notice-over-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zhengye-biotechnology-receives-deficiency-notice-over-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641162314","title":"Zhengye Biotechnology gets Nasdaq notice for US$ 1 minimum bid price deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2641162314","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641162314?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:07","pubTimestamp":1780603666,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology received a Nasdaq notice citing non-compliance with the US$ 1 minimum bid price requirement.The deficiency followed 30 straight business days with a closing bid below US$ 1, spanning April 16 to May 28, 2026.Shares remain listed for now; the company has until Nov. 25, 2026 to regain compliance by closing at or above US$ 1 for 10 days.Failure to regain compliance by the deadline could trigger delisting risk; a reverse stock split is among options under review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL3Lss1c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641162838","title":"Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2641162838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641162838?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:05","pubTimestamp":1780603501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA7QP2MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631390155","title":"Zhengye Biotech FY25 net loss widens to RMB 83 million; revenue drops 37.6% to RMB 116.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631390155","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631390155?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:05","pubTimestamp":1777410314,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology posted a net loss of RMB 82.97 million for fiscal year 2025, reversing from prior-year profit.Revenue fell 37.6% to RMB 116.36 million, driven by reduced demand for swine vaccines amid a downturn in the hog market.Operating loss widened to RMB 70.51 million as gross margin slid 28.5 percentage points to 20.5% on lower sales prices and unchanged fixed costs.Sales mix shifted, with swine vaccine revenue dropping to RMB 90.14 million while other vaccines rose to RMB 13.74 million on higher sheep vaccine sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLn8CkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631536205","title":"Zhengye Biotechnology FY EPS $(0.21) Down From $0.03 YoY, Sales $16.639M Down From $25.531M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2631536205","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631536205?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:41","pubTimestamp":1777408901,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology FY EPS $(0.21) Down From $0.03 YoY, Sales $16.639M Down From $25.531M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52113661/zhengye-biotechnology-fy-eps-0-21-down-from-0-03-yoy-sales-16-639m-down-from-25-531m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Zhengye Biotechnology FY EPS $(0.21) Down From $0.03 YoY, Sales $16.639M Down From $25.531M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631363775","title":"Press Release: Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2631363775","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631363775?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:30","pubTimestamp":1777408200,"startTime":"0","endTime":"0","summary":"Mr. Songlin Song, co-chief executive officer of Zhengye, remarked, \"Fiscal year 2025 was a year of resilience for Zhengye. While the broader hog market experienced low and volatile price fluctuations and government macro-control policies contributed to near-term pressure on swine vaccine demand, we remained focused on executing our strategy and driving long-term value creation. We are encouraged by the continued growth in our other vaccines segment, particularly vaccines for sheep, which contributed to improving our revenue mix. On the international front, we made progress in advancing vaccine registrations in certain overseas markets, including Egypt, Pakistan, and Vietnam, supporting our long-term expansion strategy.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630873608","title":"Zhengye Biotechnology files Form 3 for director Hu Qiyi","url":"https://stock-news.laohu8.com/highlight/detail?id=2630873608","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630873608?lang=en_us&edition=fundamental","pubTime":"2026-04-25 06:40","pubTimestamp":1777070413,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology said director Hu Qiyi filed an initial Form 3 beneficial ownership statement dated March 24, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL1TjC5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625674113","title":"Zhengye Biotechnology implements dual-class share structure with 20-vote Class B shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2625674113","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625674113?lang=en_us&edition=fundamental","pubTime":"2026-04-06 21:25","pubTimestamp":1775481918,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology implemented dual-class share structure effective April 7, 2026.Nasdaq trading continues under ticker ZYBT, with shares designated as Class A ordinary shares.Capital reclassified into 1.9 billion Class A shares, 100 million Class B shares.Class A carries 1 vote per share; Class B carries 20 votes per share.Class B shares can convert into Class A at holder option; reverse conversion not permitted.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL29VRX6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4007","IE00B3QW5Z07.USD","NDAQ","IE00BGHQF748.EUR","ZYBT","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","BK4588","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625674016","title":"Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2625674016","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625674016?lang=en_us&edition=fundamental","pubTime":"2026-04-06 21:25","pubTimestamp":1775481900,"startTime":"0","endTime":"0","summary":"Jilin, China, April  06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, develo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268492/0/en/Zhengye-Biotechnology-Holding-Limited-Announces-Implementation-of-Dual-Class-Share-Structure.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622024184","title":"Zhengye Biotechnology Holding held its annual general meeting; 43.13 million shares were represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2622024184","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622024184?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:03","pubTimestamp":1774432994,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology Holding held its annual general meeting of shareholders on March 24, 2026.Shareholders approved resolutions to approve the election of two director candidates and to approve the re-election of certain current directors.Votes also approved the share reclassification and the share consolidation.A special resolution to approve the adoption of the new memorandum and articles of association was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLc20Vpq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262321","title":"Zhengye Biotechnology Holding Ltd. Co-CEO Aiden Han Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262321","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262321?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:14","pubTimestamp":1773864862,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology Holding reported an initial statement of beneficial ownership naming Aiden Han as co-chief executive officer. The filing stated that Aiden Han beneficially owned no securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4YTt6R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620026231","title":"Zhengye Biotechnology Holding Ltd. Vice General Manager Lian Wei files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620026231","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620026231?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:13","pubTimestamp":1773864803,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology Holding reported that Wei Lian filed an initial statement of beneficial ownership on 03/18/2026. Wei Lian is an officer of the company, with the title Vice General Manager. The filing stated that Wei Lian beneficially owned no securities of Zhengye Biotechnology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3y8VZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614033011","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2614033011","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614033011?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:38","pubTimestamp":1772030329,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nAQN2LNO3I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYBT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613737294","title":"Zhengye Biotechnology Independent Director Wenbin Wang Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737294","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737294?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:11","pubTimestamp":1771881075,"startTime":"0","endTime":"0","summary":"Zhengye Biotechnology Holding Ltd. said independent director Wenbin Wang resigned from its board effective Feb. 18, 2026, stepping down from the audit, compensation, and nominating and corporate governance committees, including as chair of the compensation committee. The company said the resignation was for personal reasons and not due to any disagreement, and it plans to seek shareholder approval to appoint a new independent director at its March 2026 annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL7910D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612464261","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:04 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2612464261","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612464261?lang=en_us&edition=fundamental","pubTime":"2026-02-18 03:04","pubTimestamp":1771355072,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:04 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nAQN2LMIOD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZYBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}